PortfoliosLab logoPortfoliosLab logo
KBH vs. MDGL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KBH vs. MDGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KB Home (KBH) and Madrigal Pharmaceuticals, Inc. (MDGL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KBH achieves a -7.96% return, which is significantly higher than MDGL's -22.23% return. Over the past 10 years, KBH has underperformed MDGL with an annualized return of 15.29%, while MDGL has yielded a comparatively higher 42.68% annualized return.


KBH

1D
0.67%
1M
0.53%
YTD
-7.96%
6M
-19.20%
1Y
2.68%
3Y*
5.68%
5Y*
4.25%
10Y*
15.29%

MDGL

1D
-5.90%
1M
-11.85%
YTD
-22.23%
6M
-20.99%
1Y
66.08%
3Y*
20.33%
5Y*
34.53%
10Y*
42.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KBH vs. MDGL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KBH
KB Home
-7.96%-12.72%6.64%99.04%-27.48%35.29%-0.86%82.31%-39.98%103.05%
MDGL
Madrigal Pharmaceuticals, Inc.
-22.23%88.72%33.36%-20.28%242.52%-23.77%22.02%-19.17%22.80%516.04%

Correlation

The correlation between KBH and MDGL is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (10Y)
Calculated over the trailing 10-year period

0.20

Correlation (All Time)
Calculated using the full available price history since Feb 7, 2007

0.25

The correlation between KBH and MDGL shifts across timeframes, from 0.13 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KBH:

$3.28B

MDGL:

$13.15B

EPS

KBH:

$5.38

MDGL:

-$12.87

PS Ratio

KBH:

0.57

MDGL:

9.61

PB Ratio

KBH:

0.72

MDGL:

24.19

Total Revenue (TTM)

KBH:

$5.92B

MDGL:

$1.13B

Gross Profit (TTM)

KBH:

$893.19M

MDGL:

$1.05B

EBITDA (TTM)

KBH:

$477.26M

MDGL:

-$287.63M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KBH vs. MDGL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KBH
KBH Risk / Return Rank: 4040
Overall Rank
KBH Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
KBH Sortino Ratio Rank: 3838
Sortino Ratio Rank
KBH Omega Ratio Rank: 3737
Omega Ratio Rank
KBH Calmar Ratio Rank: 4141
Calmar Ratio Rank
KBH Martin Ratio Rank: 4141
Martin Ratio Rank

MDGL
MDGL Risk / Return Rank: 7777
Overall Rank
MDGL Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
MDGL Sortino Ratio Rank: 7979
Sortino Ratio Rank
MDGL Omega Ratio Rank: 7676
Omega Ratio Rank
MDGL Calmar Ratio Rank: 7676
Calmar Ratio Rank
MDGL Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KBH vs. MDGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for KB Home (KBH) and Madrigal Pharmaceuticals, Inc. (MDGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


KBHMDGLDifference

Sharpe ratio

Return per unit of total volatility

0.07

1.46

-1.39

Sortino ratio

Return per unit of downside risk

0.39

2.31

-1.92

Omega ratio

Gain probability vs. loss probability

1.04

1.27

-0.23

Calmar ratio

Return relative to maximum drawdown

0.05

2.20

-2.15

Martin ratio

Return relative to average drawdown

0.11

5.01

-4.90

KBH vs. MDGL - Sharpe Ratio Comparison

The current KBH Sharpe Ratio is 0.07, which is lower than the MDGL Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of KBH and MDGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


KBHMDGLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.07

1.46

-1.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.11

0.26

-0.15

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

0.36

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

0.16

0.02

+0.15

Drawdowns

KBH vs. MDGL - Drawdown Comparison

The maximum KBH drawdown since its inception was -92.78%, smaller than the maximum MDGL drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for KBH and MDGL.


Loading charts...

Drawdown Indicators


KBHMDGLDifference

Max Drawdown

Largest peak-to-trough decline

-92.78%

-98.40%

+5.62%

Max Drawdown (1Y)

Largest decline over 1 year

-32.85%

-29.36%

-3.49%

Max Drawdown (3Y)

Largest decline over 3 years

-48.27%

-56.45%

+8.18%

Max Drawdown (5Y)

Largest decline over 5 years

-48.27%

-61.41%

+13.14%

Max Drawdown (10Y)

Largest decline over 10 years

-72.38%

-82.19%

+9.81%

Current Drawdown

Current decline from peak

-40.90%

-24.88%

-16.02%

Average Drawdown

Average peak-to-trough decline

-43.55%

-58.57%

+15.02%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.75%

12.88%

+0.87%

Volatility

KBH vs. MDGL - Volatility Comparison

The current volatility for KB Home (KBH) is 12.02%, while Madrigal Pharmaceuticals, Inc. (MDGL) has a volatility of 14.22%. This indicates that KBH experiences smaller price fluctuations and is considered to be less risky than MDGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KBHMDGLDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.02%

14.22%

-2.20%

Volatility (6M)

Calculated over the trailing 6-month period

26.24%

30.73%

-4.49%

Volatility (1Y)

Calculated over the trailing 1-year period

36.66%

45.53%

-8.87%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

38.09%

133.39%

-95.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

44.68%

117.52%

-72.84%

Dividends

KBH vs. MDGL - Dividend Comparison

KBH's dividend yield for the trailing twelve months is around 1.94%, while MDGL has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
KBH
KB Home
1.94%1.77%1.45%1.12%1.88%1.34%1.25%1.14%0.52%0.31%0.63%0.81%
MDGL
Madrigal Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

KBH vs. MDGL - Financials Comparison

This section allows you to compare key financial metrics between KB Home and Madrigal Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.08B
311.34M
(KBH) Total Revenue
(MDGL) Total Revenue
Values in USD except per share items

KBH vs. MDGL - Profitability Comparison

The chart below illustrates the profitability comparison between KB Home and Madrigal Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
91.4%
Portfolio components
KBH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, KB Home reported a gross profit of 0.00 and revenue of 1.08B. Therefore, the gross margin over that period was 0.0%.

MDGL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a gross profit of 284.49M and revenue of 311.34M. Therefore, the gross margin over that period was 91.4%.

KBH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, KB Home reported an operating income of 32.99M and revenue of 1.08B, resulting in an operating margin of 3.1%.

MDGL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported an operating income of -92.72M and revenue of 311.34M, resulting in an operating margin of -29.8%.

KBH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, KB Home reported a net income of 33.42M and revenue of 1.08B, resulting in a net margin of 3.1%.

MDGL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a net income of -94.39M and revenue of 311.34M, resulting in a net margin of -30.3%.


Frequently Asked Questions


KBH and MDGL have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MDGL has higher volatility (14.22%) compared to KBH (12.02%). In terms of maximum drawdown, KBH dropped -92.78% vs MDGL's -98.40%.

MDGL currently has the higher Sharpe Ratio (1.46 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KBH and MDGL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer